CANbridge Pharmaceuticals Inc Sustainability Reports
CANbridge Pharmaceuticals Inc. is a global biopharmaceutical company specializing in the research, development, and commercialization of medical products, with a core focus on therapeutics for rare diseases and oncology.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00RTNTNP9
16 reports from 2021 to 2025
- CANbridge Pharmaceuticals Inc 2025 Annual Report
- CANbridge Pharmaceuticals Inc 2025 Environmental, Social and Governance Report
- CANbridge Pharmaceuticals Inc 2025 Environmental, Social and Governance Report
- CANbridge Pharmaceuticals Inc 2024 Environmental, Social and Governance Report
- CANbridge Pharmaceuticals Inc 2024 Annual Report